Skip to main content
PACB
NASDAQ Industrial Applications And Services

Officer Files Intent to Sell Nearly $480K in Company Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.6
Mkt Cap
$477.014M
52W Low
$0.851
52W High
$2.73
52W Position info
88% above low
Off High info
41% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PACB sits 88% above its 52-week low of $0.851.

Summary

An officer of Pacific Biosciences of California, Inc. has filed a Form 144 to sell approximately $478,692 worth of common stock, representing about 0.1% of the company's market cap.


Key Events · Ownership and Investor Activity · PACB

  • Officer Files Intent to Sell

    Mark Van Oene, an officer, filed a Form 144 to sell 303,739 shares of common stock.

  • Significant Value

    The proposed sale has an approximate market value of $478,692.66.

  • Post-Earnings Timing

    This intent to sell follows the company's recent report of better-than-expected Q4 results on February 12, 2026.


Analysis · PACB · Industrial Applications And Services

Mark Van Oene, an officer at Pacific Biosciences, has filed a Form 144 indicating an intent to sell approximately $478,692 worth of common stock. This proposed sale represents about 0.1% of the company's current market capitalization. The filing comes shortly after the company reported better-than-expected Q4 results on February 12, 2026, and completed a significant asset sale to Illumina on February 2, 2026. While the amount is not exceptionally large, an officer's intent to sell can be viewed as a slightly negative signal, especially following recent positive corporate news.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PACB was trading at $1.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $477M. The 52-week trading range was $0.85 to $2.73. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PACB - Latest Insights

PACB
Nov 10, 2026, 4:05 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.25
Real-time Price: $2.09 info
Change: -$0.164 (-7%) info
Market Cap: $652.452M info
PACB
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $2.09 info
Change: -$0.455 (-18%) info
Market Cap: $652.452M info
PACB
Nov 04, 2026, 5:41 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $2.09 info
Change: -$0.515 (-20%) info
Market Cap: $652.452M info
PACB
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $2.09 info
Change: -$0.595 (-22%) info
Market Cap: $652.452M info
PACB
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.57
Real-time Price: $2.09 info
Change: -$0.485 (-19%) info
Market Cap: $652.452M info